📰 Genentech News
Page 42 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
February 15, 2024
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.
February 15, 2024
On February 15, 1982, Steve Jobs appeared on the front cover of Time magazine for the first time in his career.
February 15, 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 15, 2024--
February 15, 2024
Two ads single out Davis as the co-sponsor of new legislation that would diminish Medicare’s negotiating power over drug pricing.
February 15, 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the appointm...
February 15, 2024
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript February 14, 2024 Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.32. Adaptive Biotechnologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
February 15, 2024
In 2023, the world-wide value of intangible assets (e.g., contractual rights and intellectual property (IP), such as patents, copyrights, and proprietary technology) reached USD57.
February 15, 2024
In today’s rapidly evolving safety landscape, leveraging technology is paramount to fostering a robust safety culture. Discover the positive impact of mobile environmental, health and safety apps on safety audits, inspections, incident reporting and more. Our presenters will delve into real-world examples showcasing how mobile apps can elevate safety practices, streamline processes and improve data accuracy — all while significantly enhancing overall productivity. Learn best practices for su...
February 15, 2024
-- Transformational degrader antibody conjugate company backed by leading syndicate including founding investor Versant Ventures, MPM BioImpact, Decheng Capital and Eli Lilly & Company --SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Firefly Bio emerged from stealth mode with a $94 million Series A financing co-led b...